Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate, Niyad, is a lyophilized formulation of nafamostat that acts as a regional anticoagulant for infusion into...
15 insider purchases on record · latest filing 2026-03-25.
Insiders have also filed 1 sale transaction at TLPH.